Miscarriage |
Foetal loss before 20 weeks of pregnancy (measured from the last menstrual period) |
Foetal death |
Death in utero after 20 weeks from the last menstrual period. Used as an indicator of prevalence of stillbirth |
Birth |
Covers all pregnancy outcomes after 20 weeks of pregnancy (measured from the last menstrual period) |
Birth prevalence |
Used in place of “incidence” to describe the frequency of new cases as they present to health services. Expressed in terms of affected births per 1000 live births. World Population Prospects (WPP) estimates provide the denominator, and in WPP the term “births” applies only for live births |
Baseline birth prevalence |
The birth prevalence that would obtain in the absence of any intervention |
Actual birth prevalence |
Actual births/1000 live births, allowing for the effects of interventions before or during pregnancy |
Total birth prevalence |
Includes all outcomes of affected pregnancies after 20 weeks’ gestation (termination of pregnancy, foetal death/stillbirth, live birth). Expressed as total affected births /1000 live births |
Live birth prevalence |
Affected live births/1000 live births |
Optimal care |
Standard of care available in high-income settings with equitable access to services, at any given point in time |
No care |
The level of care available in the absence of any supportive medical services |
Early mortality |
Deaths in children under 5 years of age |
Severe disability |
Disability plus significantly shortened life expectancy |
Less severe disability |
Disability with less effect on life expectancy. Ranges from less severe forms of spina bifida to “well on treatment” (e.g. congenital hypothyroidism) |
Effective cure |
A disorder that has been sufficiently corrected to allow affected individuals to live their lives free from continuing medical care, and to achieve life goals such as independent living, finding a partner, reproductive success, even with some persisting problems. It does not mean complete correction with no residual problems |